Description

Update

Sue Siegel brings 25 years experience commercializing key enabling technologies in biomedical research and healthcare.

She leads investments in personalized medicine spanning areas that include technology platforms to molecular diagnostics to online healthcare, all of which leverage the power of cross-disciplinary convergence. She partners with entrepreneurs that offer "disruptive innovation" business solutions to pressing healthcare challenges: age-onset and lifestyle-induced health conditions, consumer-driven wellness preservation, and those that improve healthcare economics.

Prior to joining MDV, Sue was President and Director of Affymetrix, Inc., a company that pioneered GeneChip®technology and was instrumental in the expansion of genomics-based personalized medicine. During her tenure, she grew Affymetrix to become a multibillion dollar market cap company.

At Amersham International (now... See More

Experience (3)

Update

Advisory Roles (2)

Update

Education (2)

Update